Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

NCT00988936 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer
Metastatic Colon/Rectum Cancer
Non-squamous Non-small Cell Lung Cancer

Interventions

DRUG: [F-18]RGD-K5

Sponsor

Siemens Molecular Imaging